Latest News Oct 27, 2021 Esperion to Participate in Upcoming Virtual Investor Conference Oct 25, 2021 ESPERION Announces Agreement to Exchange $15 Million in Principal Amount of its 4.00% Convertible Senior Subordinated Notes due 2025 for Common Stock View All News Dark Blue View All News Show all Latest Quarterly Results ESPERION Reports Second Quarter 2021 Financial Results and Provides Company Update Form 10-Q View All Earnings View All Earnings Corporate Presentation Download PDF Events Upcoming Events Nov 2, 2021 at 8:00 AM EDT Third Quarter 2021 Financial Results Past Events Oct 18, 2021 at 8:00 AM EDT Esperion Investor Update Sep 13, 2021 at 1:30 PM EDT Current Landscape and Future Directions in Treatment of Elevated Cholesterol: A Webinar with Steven Nissen, M.D. View All Events View All Events
Oct 25, 2021 ESPERION Announces Agreement to Exchange $15 Million in Principal Amount of its 4.00% Convertible Senior Subordinated Notes due 2025 for Common Stock
Sep 13, 2021 at 1:30 PM EDT Current Landscape and Future Directions in Treatment of Elevated Cholesterol: A Webinar with Steven Nissen, M.D.